For example, the expression of TRIM33 is downregulated in Pancreatic Ductal AdenoCarcinoma (PDAC), and it was shown that the inactivation of TRIM33 contributes to the development of cystic pancreatic tumors through the activation of Kras [232]. Here, TRIM33 is linked to pancreatic ductal adenocarcinoma.